Unique ID issued by UMIN | UMIN000044866 |
---|---|
Receipt number | R000051246 |
Scientific Title | A clinical study to evaluate the efficacy of body fat reduction by continuous ingestion of test food and exercise. ( SME-2021-02-FOSHUS) |
Date of disclosure of the study information | 2021/07/25 |
Last modified on | 2022/09/13 08:18:15 |
A clinical study to evaluate the efficacy of body fat reduction by continuous ingestion of test food and exercise. ( SME-2021-02-FOSHUS)
A clinical study to evaluate the efficacy of body fat reduction by continuous ingestion of test food and exercise.
A clinical study to evaluate the efficacy of body fat reduction by continuous ingestion of test food and exercise. ( SME-2021-02-FOSHUS)
A clinical study to evaluate the efficacy of body fat reduction by continuous ingestion of test food and exercise.
Japan |
Not applicable
Adult |
Others
NO
To evaluate the efficacy of body fat reduction by continuous ingestion of test food and exercise.
Efficacy
Abdominal total fat area
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Daily intake of test food and exercise for 12 weeks
Daily intake of control food and exercise for 12 weeks
20 | years-old | <= |
65 | years-old | > |
Male and Female
(1) Males and females who are -> 20 years old at the time of IC acquisition and <65 years old at the end of the study.
(2) Subject, 25 kg/m2 <- BMI < 30 kg/m2.
(3) Those who can visit to destination medical institution on the scheduled date.
(4) Those who have submitted written informed consent after fully understanding the purpose and content of this study.
(1) Those who have regular hard exercise.
(2) Those who heavy use of alcohol or smoke.
(3) Those who continuously ingest foods for specified health use, foods with functional claims, health foods, and foods that may affect body fat evaluation.
(4) Those who continuously take medicines.
(5) Those who are participating in other study or planning to participate or participated within the past 4 weeks.
(6) Those who are:
a) heart, liver, or kidney disease (including complications of other diseases)
b) having a history of cardiovascular disease
c) diabetes
d) allergic to test foods
e) having a respiratory illness
(7) Others who are judged inappropriate for participant by the investigator.
148
1st name | Takao |
Middle name | |
Last name | Tanaka |
Suntory Holdings Limited
Research Strategy Planning Department
135-8631
2-3-3 Daiba, Minato-ku, Tokyo, Japan
03-5579-1277
Takao_Tanaka@suntory.co.jp
1st name | Keisuke |
Middle name | |
Last name | Yasumoto |
Suntory Holdings Limited
Research Strategy Planning Department
135-8631
2-3-3 Daiba, Minato-ku, Tokyo, Japan
03-3182-0496
Keisuke_Yasumoto@suntory.co.jp
Suntory Holdings Limited
SUNTORY BEVARAGE & FOOD LIMITED
Profit organization
Fukuhara Clinic Clinical Trial Review Committee
1-15, Shimamatsuhigashimachi-3-chome, Eniwa-shi, Hokkaido
0123-36-8029
d-kameda@mediffom.co.jp
NO
2021 | Year | 07 | Month | 25 | Day |
Published
148
Completed
2021 | Year | 07 | Month | 14 | Day |
2021 | Year | 07 | Month | 12 | Day |
2021 | Year | 07 | Month | 26 | Day |
2022 | Year | 01 | Month | 15 | Day |
2021 | Year | 07 | Month | 14 | Day |
2022 | Year | 09 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051246